Evidence map›Paper›PMID 41420250›Full record

ReviewJournal of translational medicine2025

Liver regeneration: unraveling the molecular mechanisms and clinical application.

Ning Wang, Meihua Guo, Chu Zhang, Rujiao Jiang, Jianlei Bi, Jie Sun, Bo Liu

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Cell Sheet Technology as a Platform for Functional Regeneration.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ning Wang *Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, 116044, China.
Meihua Guo *Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, 116044, China.
Chu Zhang *College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, 116044, China.
Rujiao JiangInstitute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, 116044, China.
Jianlei BiDepartment of Medical Oncology, The Second Hospital of Dalian Medical University, No. 467 Zhongshan Road, Shahekou District, Dalian, Liaoning, 116023, China.
Jie SunInstitute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, 116044, China. sunjie@dmu.edu.cn.ORCID 0009-0007-7190-0523
Bo LiuInstitute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, 116044, China. Liub03@dmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver's exceptional capacity sets it apart from other organs in its response to various acute and chronic injuries, known as "liver regeneration". Liver regeneration is not driven by a single pathway, but is achieved through a multi-level network including hepatocyte dedifferentiation, liver progenitor cell (LPCs)activation, non-coding RNA regulation, and metabolic reprogramming. Moreover, liver regeneration research still faces challenges: precise regulation of regeneration termination signals, the tumorigenic risk of stem cell therapy, and immune rejection in personalized treatment, among other issues, need to be addressed urgently. In this review, we delineate the cellular dynamics of liver regeneration and synthesize numerous signaling pathways and factors that prominently contribute to liver regeneration alongside recent research advancements. As well as its current clinical application including molecular therapy, stem cell therapy, and the development of artificial livers. We also discuss some of the current problems and look forward to new treatments. By integrating findings from numerous studies, it provides a comprehensive understanding of liver regeneration, highlighting its significance in treating liver diseases and guiding future research.

Indexed as

Liver RegenerationAnimalsHepatocytesHumansLiverSignal TransductionStem CellsCell sourceClinical trialLiver regenerationMechanismsNovel clinical exploration

Identifiers

PMID41420250
PMCPMC12717721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.